Abstract
Gastric myeloid sarcoma (MS) is a rare disease with numerous endoscopic manifestations and is typically diagnosed on the basis of immunohistochemistry. However, the epidemiology, treatment, and prognosis of gastric MS remain controversial. The goal of this study is to preliminarily analyze these controversial aspects of gastric MS.